ALMS

Alumis Inc.
CAPPED RATING

Alumis Inc. (ALMS) is rated C (2.4/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B-); its weakest is Momentum (D). The rating has held at C for 8 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.4 / 5.0
C
Value
C
Factor Score 2.4 / 5.0
Growth
B-
Factor Score 3.0 / 5.0
Profitability
B-
Factor Score 3.0 / 5.0
Momentum
D
Factor Score 1.2 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -1.8
EV / EBITDA -0.6
Rev Growth YoY -7.7%
Gross Margin N/M
Price Return 3M -79.3%
Price Return 12M -2.6%
Catalyst Signal 0.00
Market Cap $667.3M
TTM Revenue $7.2M
Price / Sales 92.2
ROE -110.9%

Historical Factor Score Progression

Held C for 8 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 C (2.4) B- (3.0) B- (3.0) D (1.2) C+ (2.6) C (2.4)
2026-11-10 C (2.2) C+ (2.7) B- (3.0) D+ (1.5) C+ (2.6) C (2.4)
2026-11-03 C (2.3) C+ (2.7) B- (2.9) D (1.4) C+ (2.7) C (2.4)
2026-10-27 C (2.3) C+ (2.7) B- (2.9) D (1.5) C+ (2.6) C (2.4)
2026-10-20 C (2.4) C+ (2.7) B- (2.9) D+ (1.5) C+ (2.6) C (2.4)
Page 1 of 4